https://www.selleckchem.com/pr....oducts/gusacitinib.h
Liquid biopsy is a novel tool in oncology. It provides minimally invasive detection of tumor specific DNA. This review summarizes data on presence of circulating tumor DNA in serum or plasma of CRC patients as a potential negative prognostic factor. The systematic review was performed according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). The search was performed using PubMed, Web of Science and Scopus. In total 18 articles with a total of 1779 patients met the inclusion criteria. Six out of 8 stud
Like
Comment
Share
